)
Daniel A. Kamkar's practice focuses on worldwide patent prosecution and portfolio management, patent infringement and validity analyses, freedom to operate analyses, USPTO proceedings, and general IP licensing.
Daniel currently assists various clients in a wide range of technological fields including pharmaceuticals, clean energy, polymer sciences, lasers, and other areas of chemistry and physics.
Daniel received his J.D. from the University of Washington School of Law, where he worked in the Entrepreneurial Law Clinic and the University of Washington’s Technology Transfer Office (CoMotion).
Before attending law school, Daniel earned his M.S. in materials chemistry from the University of California, Santa Barbara, where he researched organic semiconducting materials used to form LED's and solar cells using atomic force microscopy, photoluminescent spectroscopy, and ultrafast spectroscopic techniques.
Daniel joined the firm in 2016.
Kerry Taylor, Daniel Kamkar, Joel Broussard, "IPR Appeals in 2017: The Pendency And Success Rates," Law360 (January 2018).
Daniel Kamkar, Agnes Juang, Ph.D., "The Complex Litigation Surrounding Remicade And Its Biosimilar Challengers," Biosimilar Development (2017)
Christopher T. Sweeney, "What pharma should know about the European Unitary Patent in light of Brexit", July 17, 2017
Daniel Kamkar, Kerry Taylor, "IPR Appeals: Pendency And Success Rates At Fed. Circ." Law360 (February 2017).
Kamkar, Daniel A., et al. "Single nanowire OPV properties of a fullerene-capped P3HT dyad investigated using conductive and photoconductive AFM." ACS nano 6.2 (2012): 1149-1157.
Zalar, Peter, et al. "DNA electron injection interlayers for polymer light-emitting diodes." Journal of the American Chemical Society 133.29 (2011): 11010-11013.
Caputo, Bruno JA, et al. "A Dithienosilole‐Benzooxadiazole Donor–Acceptor Copolymer for Utility in Organic Solar Cells." Small 7.10 (2011): 1422-1426.